Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2 Suppl):21S-32S.

Antiblastic treatment of haematological malignancies during pregnancy: a crucial decision.

Michieli M, Peccatori FA, Lleshi A, Del Pup L, Valente D, Rupolo M, Tirelli U, Berretta M.
SourceDepartment of Medical Oncology, National Cancer Institute, Aviano (PN), Italy. mmichieli@cro.it

Abstract

Antiblastic treatment of hematological malignancies during pregnancy poses a number of issues related to the curability of the maternal disease, the need of a prompt treatment and the potential toxicity of chemotherapy for the fetus. Here we report the results of a systematic literature search about the management of the most frequent hematological malignancies that may occur during pregnancy, focusing on specific issues related to gestational age at diagnosis, fetal toxicity and efficacy on the maternal side. The standard approach in non-pregnant women is illustrated as reference.


«  indice delle pubblicazioni più recenti